Furthermore, inflammation could stimulate tumor cells to express immune checkpoint molecules, such as programmed cell death 1 ligand 1 (PD-L1), thereby inhibiting T lymphocyte activity and proliferation [26, 28]. The gene discussed is CD274; the disease is neoplasm.